Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Gene Therapy

Argentinian couple moves to US to allow their toddler to join gene therapy trial

The Lovatos relocated from Guatemala to Ohio for their son, who has the rare genetic disorder Canavan disease

The Guardian - US

Deaf baby can hear after 'mind-blowing' gene therapy treatment

Seven months after her treatment, the baby girl can now respond to her parents' voices without the aid of a cochlear implant.

LiveScience

Great Ormond Street hoping to license gene therapy for ‘bubble baby’ syndrome

Hospital to take unprecedented step after drug firm pulled out despite successful trial of treatment

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

UK toddler has hearing restored in world first gene therapy trial

Opal Sandy can hear almost perfectly after groundbreaking surgery that took just 16 minutes

The Guardian - UK

Pfizer reports patient death in Duchenne gene therapy study

Pfizer's gene therapy trial for Duchenne muscular dystrophy resulted in a young patient's death from cardiac arrest

The Hindu

Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure

The FDA approved Pfizer's hemophilia gene therapy on Friday. But Pfizer stock only inched ahead on the approval early Friday.

Investors Business Daily

3 Standout Penny Stocks to Watch This April

Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according to Wall Street.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Gene Therapy Breakthroughs In The 1990S Revolutionized Medical Treatment.

Explore the pivotal era of gene therapy in the 1990s, from groundbreaking advancements to significant challenges, shaping modern regenerative medicine.

Top News

How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback

Solid Biosciences is shrugging off several messy years in gene therapy development. The biotech stock has gotten a triple-digit boost.

Investors Business Daily

Kyowa Kirin Gene Therapy: Most Expensive US Drug At .3M

Kyowa Kirin's .3 million gene therapy sparks debate on accessibility and pricing of innovative treatments in the US.

Top News

Kyowa Kirin's Gene Therapy: Most Expensive US Drug

Kyowa Kirin's .3 million gene therapy sparks debates on accessibility and affordability in healthcare.

Top News

Ensuring Quality Control In Cell And Gene Therapy Manufacturing

Learn about the importance of quality control in cell and gene therapy manufacturing for patient safety and market success.

Top News

German firm Miltenyi Biotec opens office, plans Cell and Gene Therapy CoE

Miltenyi Biotec launches operations in Hyderabad, investing in a Cell and Gene Therapy centre of excellence.

The Hindu

Exploring The Top 10 Genetic Engineering Breakthroughs

Explore the latest breakthroughs in genetic engineering, from CRISPR-Cas9 to gene therapy, and their impact on healthcare and conservation.

Top News

Get all your
news in one place.

100’s of premium titles.
One news app.

Dynamite News

Heart Attack: Gene therapy improves advanced heart failure in animal model

During a heart attack, blood stops flowing into the heart. Without oxygen, a portion of the heart muscle dies. Read further on Dynamite News:

Dynamite News

Gene therapy may slow progression of a life-threatening cardiac ailment

The investigational treatment targets the loss of function of a gene implicated in many cases of ARVC, plakophilin-2 (PKP2). Read further on Dynamite News:

The Guardian - UK

Gene therapy hailed as ‘medical magic wand’ for hereditary swelling disorder

Single-dose treatment transformed lives of patients with potentially deadly condition in first human trial

LiveScience

Gene therapies restore hearing in several kids with inherited deafness

Two new gene therapies show promise in treating otoferlin-related deafness, an inherited condition.

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

Gene therapy shows promise for an inherited form of deafness

Scientists report that gene therapy restored at least some hearing and speech for five out of six children with a rare form of genetic deafness.

Investors Business Daily

IBD Stock Of The Day Eli Lilly Is Back In A Buy Zone. And It's Not Related To Obesity.

Eli Lilly stock is Wednesday's IBD Stock Of The Day. Shares are rallying on a gene therapy that could restore hearing loss.

International Business Times

Deaf Boy Can Now Hear After Breakthrough Gene Treatment

His father's voice, the sounds of passing cars and scissors clipping his hair: An 11-year-old boy is hearing for the first time in his life after receiving a breakthrough gene therapy.

Investors Business Daily

Novartis Sweetens Its Deal With Voyager, And VYGR Stock Flashes A Bullish Sign

Novartis expanded its gene therapy collaboration with Voyager on Tuesday, and VYGR stock rocketed above its 200-day line.

Inverse

We Are About to Enter the Golden Age of Gene Therapy

The discovery of CRISPR has allowed us to enter a new era of disease treatment. Here’s what 2024 and beyond has in store for our gene-edited future.

Evening Standard

'It could change lives': Inside London lab testing gene therapy for cancer and obesity

Meira GTx, in Shoreditch, is working on potentially revolutionary treatments for a wide array of illnesses

Fortune

Bryan Johnson is being used as a human guinea pig in unproven tests to reprogram human genes in an island off Honduras

At $25,000 a go, the gene therapy works by turbocharging the body’s production of follistatin. It is, according to Minicircle Inc, the small US startup behind the therapy one of humanity’s best hopes for “extreme longevity”.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.